Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

BRD0705

SKU: orb1309904

Description

BRD0705 is a potent, orally bioavailable small molecule inhibitor with significant selectivity for GSK3α over GSK3β. It is a valuable research tool for investigating the distinct roles of GSK3 paralogs in cellular signaling, proliferation, and in vivo models of disease.

Research Area

Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

Key Properties

CAS Number2056261-41-5
MW321.42
Purity99.59% (May vary between batches)
FormulaC20H23N3O
SMILESCC[C@@]1(C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2)c1ccccc1
TargetGSK-3
SolubilityDMSO:300 mg/mL (933.36 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (15.56 mM)

Bioactivity

Target IC50
GSK-3α:4.8 μM (Kd)|GSK-3α:66 nM|GSK-3β (WT):515 nM
In Vivo
In AML mouse models, BRD0705 (30 mg/kg; oral gavage; twice daily; NSG mice) treatment impairs leukemia initiation and prolongs survival.
In Vitro
BRD0705 displays excellent selectivity in a penal of 311 kinases, the CDK family of kinases (CDK2, 3 and 5) are next most potently inhibits at values of 6.87 μM, 9.74 μM and 9.20 μM (87-fold, 123-fold and 116-fold selectivity relative to GSK3α). BRD0705 (10-40 μM; 2-24 hours; U937 cells) treatment impairs GSK3α Tyr279 phosphorylation in a time-and concentration-dependent manner without affecting GSK3β Tyr216 phosphorylation. BRD0705 impairs AML colony formation in all six tested cell lines, MOLM13, TF-1, U937, MV4-11, HL-60, and NB4, in a concentration-dependent manner, as opposed to BRD3731 which impairs colony formation in TF-1 while increasing colony-forming ability in the MV4-11 cell line.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

β-catenin, survival, GSK-3β(WT), GSK-3α, GSK3α, GSK-3, GSK3, Glycogen synthase kinase-3, Glycogen synthase kinase 3, leukemia, Inhibitor, oral, inhibit, kinase, myeloid, BRD 0705, BRD0705, BRD-0705, bioavailability, Acute

Similar Products

  • BRD5648 [orb1309903]

    99.89% (May vary between batches)

    2056261-42-6

    321.42

    C20H23N3O

    1 ml x 10 mM (in DMSO), 1 mg, 5 mg, 10 mg, 25 mg, 50 mg
  • (Rac)-BRD0705 [orb1309178]

    99.70% (May vary between batches)

    1597440-03-3

    321.42

    C20H23N3O

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 130.00
5 mg
$ 240.00
1 ml x 10 mM (in DMSO)
$ 260.00
10 mg
$ 320.00
25 mg
$ 460.00
50 mg
$ 630.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry